Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and Management

被引：0
|
作者：
Sood, Siddhartha [1 ]
Bagit, Ahmed [1 ]
Waked, Jihad Abou Ali [2 ]
Perlmutter, Jonah [1 ]
Tarafdar, Nawar [2 ]
Maliyar, Khalad [3 ]
Sachdeva, Muskaan [3 ]
Abduelmula, Abrahim [3 ]
Mufti, Asfandyar [3 ,4 ]
Yeung, Jensen [3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Western Ontario, Fac Med, London, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
[6] Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年
关键词：
severe cutaneous adverse reaction; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; acute generalized exanthematous pustulosis; immune checkpoint inhibitor; systematic review;
D O I：
10.1177/12034754251320632
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management
    Mustafa, S. Shahzad
    Ostrov, David
    Yerly, Daniel
    CURRENT ALLERGY AND ASTHMA REPORTS, 2018, 18 (04)
  • [32] Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions
    Zhang, Xiang
    Lu, Wen-Shen
    Qin, Xiao-Ming
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2020, 40 (04): : 172 - 181
  • [33] Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis
    Bomze, David
    Sprecher, Eli
    Geller, Shamir
    JOURNAL OF DERMATOLOGY, 2022, 49 (08): : 769 - 774
  • [34] Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
    Dao, Ro-Lan
    Su, Shih-Chi
    Chung, Wen-Hung
    ASIA PACIFIC ALLERGY, 2015, 5 (02) : 59 - 67
  • [35] Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
    Su, Shih-Chi
    Hung, Shuen-Iu
    Fan, Wen-Lang
    Dao, Ro-Lan
    Chung, Wen-Hung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)
  • [36] Toxicities associated with immune checkpoint inhibitors: a systematic study
    Kong, Xiangyi
    Chen, Li
    Su, Zhaohui
    Sullivan, Ryan J.
    Blum, Steven M.
    Qi, Zhihong
    Liu, Yulu
    Huo, Yujia
    Fang, Yi
    Zhang, Lin
    Gao, Jidong
    Wang, Jing
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (06) : 1753 - 1768
  • [37] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
    Kloypan, Chiraphat
    Koomdee, Napatrupron
    Satapornpong, Patompong
    Tempark, Therdpong
    Biswas, Mohitosh
    Sukasem, Chonlaphat
    PHARMACEUTICALS, 2021, 14 (11)
  • [38] TNF-α inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series
    Chu, Yanjun
    Xu, Mengjun
    Dong, Xiaoqing
    Zhou, Jiong
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [39] A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitorsaEuro
    Chen, T. W.
    Razak, A. R.
    Bedard, P. L.
    Siu, L. L.
    Hansen, A. R.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1824 - 1829
  • [40] Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
    Gan, Linyang
    Chen, Huan
    Liu, Xiaowei
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345